CLINICAL_TRIALS
trial_result
· 2017-08-02
Clinical Trial Update: 723/726 Proof of Concept Study in Allergen Challenge Chamber in Hannover [Phase 2]
Summary
Phase 2 proof-of-concept study in an allergen challenge chamber for seasonal allergic rhinitis completed; results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: GlaxoSmithKline | Conditions: Rhinitis, Allergic, Seasonal | Phase 2 | Status: COMPLETED | Results posted: 2017-08-02